WDR91 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB100-77307
Conjugate
Catalog #
Key Product Details
Validated by
Independent Antibodies, Biological Validation
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
1.0 mg/ml
Product Specifications
Immunogen
The immunogen recognized by this antibody maps to a region between residue 350 and 400 of human WD repeat domain 91 using the numbering given in entry NP_054868.2 (GeneID 29062).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for WDR91 Antibody
Immunohistochemistry-Paraffin: WDR91 Antibody [NB100-77307]
Immunohistochemistry-Paraffin: WDR91 Antibody [NB100-77307] - Sample: FFPE section of human prostate carcinoma. Antibody: Affinity purified rabbit anti- WDR91 used at a dilution of 1:1,000 (1ug/ml). Detection: DABApplications for WDR91 Antibody
Application
Recommended Usage
Immunohistochemistry
1:500 - 1:2000
Immunohistochemistry-Paraffin
1:500 - 1:2000
Immunoprecipitation
2 - 5 ug/mg lysate
Western Blot
1:2000-1:10000
Application Notes
Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris-Citrate/Phosphate (pH 7.0 - 8.0)
Preservative
0.09% Sodium Azide
Concentration
1.0 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: WDR91
Alternate Names
HSPC049, WD repeat domain 91, WD repeat-containing protein 91
Entrez Gene IDs
29062 (Human)
Gene Symbol
WDR91
UniProt
Additional WDR91 Products
Product Documents for WDR91 Antibody
Product Specific Notices for WDR91 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...